Description

Book Synopsis


Table of Contents

Section 1: Epidemiology

  1. Association Between Glycemic Status and the Risk of Parkinson Disease: A Nationwide Population-Based Study
  2. Effects of Vitamin D Supplementation on Prevention of Type 2 Diabetes in Patients with Prediabetes: A Systematic Review and Meta-analysis
  3. Screening and Treatment Outcomes in Adults and Children with Type 1 Diabetes and Asymptomatic Celiac Disease: The CD-DIET Study
  4. Adolescent Obesity and Early-Onset Type 2 Diabetes
  5. Bone Mass and Density in Youth with Type 2 Diabetes, Obesity, and Healthy Weight
  6. White Rice Intake and Incident Diabetes: A Study of 132,373 Participants in 21 Countries
  7. Sleep Duration Patterns in Early to Middle Adulthood and Subsequent Risk of Type 2 Diabetes in Women
  8. Prognostic Significance of Long-term HbA1c Variability for All-Cause Mortality in the ACCORD Trial
  9. Using the BRAVO Risk Engine to Predict Cardiovascular Outcomes in Clinical Trials with Sodium-Glucose Transporter 2 Inhibitors
  10. Influenza Vaccination is Associated with Reduced Cardiovascular Mortality in Adults with Diabetes: A Nationwide Cohort Study
  11. Immune Checkpoint Inhibitor-Associated Diabetes: A Single-Institution Experience
  12. Risk of Anemia with Metformin Use in Type 2 Diabetes: A MASTERMIND Study
  13. Association of Serum 25-Hydroxyvitamin D Concentrations with All-Cause and Cause-Specific Mortality Among Individuals With Diabetes
  14. Long-term Follow-up of Glycemic and Neurological Outcomes in an International Series of Patients with Sulfonylurea-Treated ABCC8 Permanent Neonatal Diabetes
  15. Accuracy of 1-Hour Plasma Glucose During the Oral Glucose Tolerance Test in Diagnosis of Type 2 Diabetes in Adults: A Meta-analysis
  16. Worldwide Epidemiology of Diabetes-Related End-Stage Renal Disease, 2000–2015
  17. Metabolic Impact of Intermittent Fasting in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Interventional Studies
  18. Foot Care Practices Among Diabetologists in India: A Descriptive Study by the Diabetic Foot Research India
  19. Impact of Age at Type 2 Diabetes Mellitus Diagnosis on Mortality and Vascular Complications: Systematic Review and Meta-analyses
    Anti-Mullerian Hormone Levels and Risk of Type 2 Diabetes in Women
  20. Risk of Type 2 Diabetes Mellitus in Women with Prior Hypertensive Disorders of Pregnancy: A Systematic Review and Meta-analysis

Section 2: Basic Science

  1. The Effect of Vitamin D Supplementation on Insulin Sensitivity: A Systematic Review and Meta-analysis
  2. Microbiota-Related Metabolites and the Risk of Type 2 Diabetes
  3. Role of Patatin-Like Phospholipase Domain – Containing 3 Gene for Hepatic Lipid Content and Insulin Resistance in Diabetes
  4. Plasma Metabolomics Identifies Markers of Impaired Renal Function: A Meta-analysis of 3,089 Persons with Type 2 Diabetes
  5. Two Decades Since the Fetal Insulin Hypothesis: What Have We Learned from Genetics?

Section 3: Comorbidities

  1. Association of Type 2 Diabetes with Cancer: A Meta-analysis with Bias Analysis for Unmeasured Confounding in 151 Cohorts Comprising 32 Million People
  2. Post Pancreatitis Diabetes Confers Higher Risk for Pancreatic Cancer Than Type 2 Diabetes: Results from a Nationwide Cancer Registry
  3. Incidence of Hospitalization for Heart Failure Relative to Major Atherosclerotic Events in Type 2 Diabetes: A Meta-analysis of Cardiovascular Outcomes Trials
  4. Influence of Renin-Angiotensin System Inhibitors on Lower– Respiratory Tract Infections in Type 2 Diabetes: The Fremantle Diabetes Study Phase II
  5. The Close Link of Pancreatic Iron with Glucose Metabolism and With Cardiac Complications in Thalassemia Major: A Large, Multicentre Observational Study
  6. Rapid Changes in Serum Testosterone in Men with Newly Diagnosed Type 2 Diabetes with Intensive Insulin and Metformin
  7. Antidiabetes Agents and Incident Depression: A Nationwide Population-Based Study
  8. Rapid Exocrine Pancreatic Dysfunction in Diabetes: An Observational Study
  9. Screening Strategies for Non-alcoholic Fatty Liver Disease in Type 2 Diabetes: Insights from NHANES 2005–2016
  10. Effect of Depression on Mortality in Type 2 Diabetes Mellitus After 8 Years of Follow-up. The DIADEMA Study
  11. Diabesity Negatively Affects Transferrin Saturation and Iron Status. The DICARIVA Study
  12. The Investigation of Diabetes in People Living with HIV: A Systematic Review

Section 4: Complications

  1. The Hospitalization for Lactic Acidosis Among Patients with Reduced Kidney Function Treated with Metformin or Sulfonylureas
  2. Opposing Associations of NT-proBNP with Risks of Diabetes and Diabetes-Related Complications
  3. HbA1c Change and Diabetic Retinopathy During GLP-1 Receptor Agonist Cardiovascular Outcome Trials: A Meta- analysis and Meta-regression
  4. Evaluation of Platelet Volume Indices as Predictive Biomarkers of Microvascular Complications in Patients with Type 2 Diabetes
  5. Heart Failure Among People with Type 2 Diabetes Mellitus: Real-world Data of 289 954 People from a Diabetes Database

Section 5: Type 1 Diabetes Mellitus

  1. Time in Range for Multiple Technologies in Type 1 Diabetes: A Systematic Review and Network Meta-analysis
  2. Hierarchical Order of Distinct Autoantibody Spreading and Progression to Type 1 Diabetes in the TEDDY Study
  3. A Comparison of Familial and Sporadic Type 1 Diabetes Among Young Patients
  4. A Validated Prediction Model for End-Stage Kidney Disease in Type 1 Diabetes
  5. Association of Implementation of a Comprehensive Preconception-to- Pregnancy Management Plan with Pregnancy Outcomes Among Chinese Pregnant Women with Type 1 Diabetes: The CARNATION Study
  6. Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) in Patients with Type 1 Diabetes Mellitus: A Systematic Review and Meta-analysis

Section 6: Gestational Diabetes Mellitus

  1. Prevention of Gestational Diabetes Mellitus in Overweight or Obese Pregnant Women: A Network Meta-analysis
  2. Maternal Age and the Risk of Gestational Diabetes Mellitus: A Systematic Review and Meta-analysis of Over 120 Million Participants
  3. Gestational Diabetes Mellitus in HIV-infected Pregnant Women: A Systematic Review and Meta-analysis
  4. Continuous Glucose Monitoring in Pregnancy: Importance of Analyzing Temporal Profiles to Understand Clinical Outcomes
  5. Urinary and Serum Angiogenic Markers in Women with Pre-existing Diabetes During Pregnancy and Their Role in Preeclampsia Prediction

Section 7: Drugs and Therapeutics

  1. Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Non-alcoholic Steatohepatitis in Patients with Type 2 Diabetes
  2. Efficacy of Modern Diabetes Treatments DPP-4i, SGLT-2i, and GLP-1RA in White and Asian Patients with Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials
  3. Clinical and Public Health Implications of 2019 Endocrine Society Guidelines for Diagnosis of Diabetes in Older Adults
  4. Efficacy and Safety of Glimepiride With or Without Linagliptin Treatment in Patients with HNF1A Diabetes (Maturity-Onset Diabetes of the Young Type 3): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial (GLIMLINA)
  5. The Impact of Bariatric Surgery on Incident Microvascular Complications in Patients with Type 2 Diabetes: A Matched Controlled Population-Based Retrospective Cohort Study
  6. Dasiglucagon — A Next-Generation Glucagon Analog for Rapid and Effective Treatment of Severe Hypoglycemia: Results of Phase 3 Randomized Double-Blind Clinical Trial
  7. Meta-analyses of Results from Randomized Outcome Trials Comparing Cardiovascular Effects of SGLT2is and GLP-1RAs in Asian Versus White Patients With and Without Type 2 Diabetes
  8. Antidepressant Use and Glycemic Control in Diabetic Population: A Meta-analysis
  9. Efficacy and Safety of Endothelin Receptor Antagonists in Type 2 Diabetic Kidney Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials
  10. Diabetes Remission Status During Seven-year Follow-up of the Longitudinal Assessment of Bariatric Surgery Study
  11. Insights Into the Early Use of Oral Semaglutide in Routine Clinical Practice: The IGNITE Study
  12. IRWIS (IDegLira Real world Indian Study): A Real-World Observational Study For Use of IDegLira In Indian Patients
  13. Insulin DEgludec in Hospitalized Patients with Type 2 Diabetes (IDEOS Study): What Effects on Glycemic Control, Glycemic Variability and Hypoglycemia
  14. Efficacy and Safety of Insulin Degludec in Renal Transplant Recipients with Pre-existing Diabetes
  15. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 Trial)
  16. Semaglutide 2·4 mg Once a Week in Adults with Overweight or Obesity, and Type 2 Diabetes (STEP 2): a Randomised, Double-blind, Double-dummy, Placebo-controlled, Phase 3 Trial
  17. A Randomized Trial Evaluating the Efficacy and Safety of Fast Acting Insulin Aspart Compared with Insulin Aspart, Both in Combination with Insulin Degludec With or Without Metformin, in Adults with Type 2 Diabetes (ONSET 9)
  18. Impact of Fast-Acting Insulin Aspart on Glycemic Control in Patients with Type 1 Diabetes Using Intermittent- Scanning Continuous Glucose Monitoring Within a Real-World Setting: The GoBolus Study
  19. Critical Appraisals
  20. Understanding Patients’ Willingness to Pay for Biphasic Insulin Aspart 30/70 in a Pen Device for Type 2 Diabetes Treatment in an Out-of-Pocket Payment Market
  21. Saroglitazar, a PPAR Agonist, for Treatment of NAFLD: A Randomized Controlled Double-Blind Phase 2 Trial
  22. Effectiveness of the PPAR Agonist Saroglitazar in Non-alcoholic Steatohepatitis: Positive Data from Preclinical and Clinical Studies
  23. Section 8: Newer Technologies and Future Directions
  24. Dual-Hormone Closed-Loop System Using a Liquid Stable Glucagon Formulation Versus Insulin-Only Closed-Loop System Compared with a Predictive Low Glucose Suspend System: An Open-Label, Outpatient, Single-Center, Crossover, Randomized Controlled Trial
  25. Effect of Flash Glucose Monitoring on Glycemic Control, Hypoglycemia, Diabetes-Related Distress, and Resource Utilization in the Association of British Clinical Diabetologists (ABCD) Nationwide Audit
  26. Diagnosis of Neuropathy and Risk Factors for Corneal Nerve Loss in Type 1 and Type 2 Diabetes: A Corneal Confocal Microscopy Stud
  27. Whole Plantar Nerve Conduction Study: A New Tool for Early Diagnosis of Peripheral Diabetic Neuropathy
  28. The Role of Infrared Dermal Thermometry in the Management of Neuropathic Diabetic Foot Ulcers
  29. Precision Medicine in Diabetes: A Consensus Report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

RSSDI Yearbook of Diabetes 2022

    Product form

    £63.65

    Includes FREE delivery

    RRP £67.00 – you save £3.35 (5%)

    Order before 4pm tomorrow for delivery by Thu 13 Aug 2026.

    A Paperback / softback by Sujoy Ghosh

    Out of stock

      Trusted by thousands of customers. See 2,385+ Customer Reviews

      View other formats and editions of RSSDI Yearbook of Diabetes 2022 by Sujoy Ghosh

      Publisher: Jaypee Brothers Medical Publishers
      Publication Date: Publication Date: 31/08/2022
      ISBN13: 9789354657740, 978-9354657740
      ISBN10: 9354657745

      Description

      Book Synopsis


      Table of Contents

      Section 1: Epidemiology

      1. Association Between Glycemic Status and the Risk of Parkinson Disease: A Nationwide Population-Based Study
      2. Effects of Vitamin D Supplementation on Prevention of Type 2 Diabetes in Patients with Prediabetes: A Systematic Review and Meta-analysis
      3. Screening and Treatment Outcomes in Adults and Children with Type 1 Diabetes and Asymptomatic Celiac Disease: The CD-DIET Study
      4. Adolescent Obesity and Early-Onset Type 2 Diabetes
      5. Bone Mass and Density in Youth with Type 2 Diabetes, Obesity, and Healthy Weight
      6. White Rice Intake and Incident Diabetes: A Study of 132,373 Participants in 21 Countries
      7. Sleep Duration Patterns in Early to Middle Adulthood and Subsequent Risk of Type 2 Diabetes in Women
      8. Prognostic Significance of Long-term HbA1c Variability for All-Cause Mortality in the ACCORD Trial
      9. Using the BRAVO Risk Engine to Predict Cardiovascular Outcomes in Clinical Trials with Sodium-Glucose Transporter 2 Inhibitors
      10. Influenza Vaccination is Associated with Reduced Cardiovascular Mortality in Adults with Diabetes: A Nationwide Cohort Study
      11. Immune Checkpoint Inhibitor-Associated Diabetes: A Single-Institution Experience
      12. Risk of Anemia with Metformin Use in Type 2 Diabetes: A MASTERMIND Study
      13. Association of Serum 25-Hydroxyvitamin D Concentrations with All-Cause and Cause-Specific Mortality Among Individuals With Diabetes
      14. Long-term Follow-up of Glycemic and Neurological Outcomes in an International Series of Patients with Sulfonylurea-Treated ABCC8 Permanent Neonatal Diabetes
      15. Accuracy of 1-Hour Plasma Glucose During the Oral Glucose Tolerance Test in Diagnosis of Type 2 Diabetes in Adults: A Meta-analysis
      16. Worldwide Epidemiology of Diabetes-Related End-Stage Renal Disease, 2000–2015
      17. Metabolic Impact of Intermittent Fasting in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Interventional Studies
      18. Foot Care Practices Among Diabetologists in India: A Descriptive Study by the Diabetic Foot Research India
      19. Impact of Age at Type 2 Diabetes Mellitus Diagnosis on Mortality and Vascular Complications: Systematic Review and Meta-analyses
        Anti-Mullerian Hormone Levels and Risk of Type 2 Diabetes in Women
      20. Risk of Type 2 Diabetes Mellitus in Women with Prior Hypertensive Disorders of Pregnancy: A Systematic Review and Meta-analysis

      Section 2: Basic Science

      1. The Effect of Vitamin D Supplementation on Insulin Sensitivity: A Systematic Review and Meta-analysis
      2. Microbiota-Related Metabolites and the Risk of Type 2 Diabetes
      3. Role of Patatin-Like Phospholipase Domain – Containing 3 Gene for Hepatic Lipid Content and Insulin Resistance in Diabetes
      4. Plasma Metabolomics Identifies Markers of Impaired Renal Function: A Meta-analysis of 3,089 Persons with Type 2 Diabetes
      5. Two Decades Since the Fetal Insulin Hypothesis: What Have We Learned from Genetics?

      Section 3: Comorbidities

      1. Association of Type 2 Diabetes with Cancer: A Meta-analysis with Bias Analysis for Unmeasured Confounding in 151 Cohorts Comprising 32 Million People
      2. Post Pancreatitis Diabetes Confers Higher Risk for Pancreatic Cancer Than Type 2 Diabetes: Results from a Nationwide Cancer Registry
      3. Incidence of Hospitalization for Heart Failure Relative to Major Atherosclerotic Events in Type 2 Diabetes: A Meta-analysis of Cardiovascular Outcomes Trials
      4. Influence of Renin-Angiotensin System Inhibitors on Lower– Respiratory Tract Infections in Type 2 Diabetes: The Fremantle Diabetes Study Phase II
      5. The Close Link of Pancreatic Iron with Glucose Metabolism and With Cardiac Complications in Thalassemia Major: A Large, Multicentre Observational Study
      6. Rapid Changes in Serum Testosterone in Men with Newly Diagnosed Type 2 Diabetes with Intensive Insulin and Metformin
      7. Antidiabetes Agents and Incident Depression: A Nationwide Population-Based Study
      8. Rapid Exocrine Pancreatic Dysfunction in Diabetes: An Observational Study
      9. Screening Strategies for Non-alcoholic Fatty Liver Disease in Type 2 Diabetes: Insights from NHANES 2005–2016
      10. Effect of Depression on Mortality in Type 2 Diabetes Mellitus After 8 Years of Follow-up. The DIADEMA Study
      11. Diabesity Negatively Affects Transferrin Saturation and Iron Status. The DICARIVA Study
      12. The Investigation of Diabetes in People Living with HIV: A Systematic Review

      Section 4: Complications

      1. The Hospitalization for Lactic Acidosis Among Patients with Reduced Kidney Function Treated with Metformin or Sulfonylureas
      2. Opposing Associations of NT-proBNP with Risks of Diabetes and Diabetes-Related Complications
      3. HbA1c Change and Diabetic Retinopathy During GLP-1 Receptor Agonist Cardiovascular Outcome Trials: A Meta- analysis and Meta-regression
      4. Evaluation of Platelet Volume Indices as Predictive Biomarkers of Microvascular Complications in Patients with Type 2 Diabetes
      5. Heart Failure Among People with Type 2 Diabetes Mellitus: Real-world Data of 289 954 People from a Diabetes Database

      Section 5: Type 1 Diabetes Mellitus

      1. Time in Range for Multiple Technologies in Type 1 Diabetes: A Systematic Review and Network Meta-analysis
      2. Hierarchical Order of Distinct Autoantibody Spreading and Progression to Type 1 Diabetes in the TEDDY Study
      3. A Comparison of Familial and Sporadic Type 1 Diabetes Among Young Patients
      4. A Validated Prediction Model for End-Stage Kidney Disease in Type 1 Diabetes
      5. Association of Implementation of a Comprehensive Preconception-to- Pregnancy Management Plan with Pregnancy Outcomes Among Chinese Pregnant Women with Type 1 Diabetes: The CARNATION Study
      6. Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) in Patients with Type 1 Diabetes Mellitus: A Systematic Review and Meta-analysis

      Section 6: Gestational Diabetes Mellitus

      1. Prevention of Gestational Diabetes Mellitus in Overweight or Obese Pregnant Women: A Network Meta-analysis
      2. Maternal Age and the Risk of Gestational Diabetes Mellitus: A Systematic Review and Meta-analysis of Over 120 Million Participants
      3. Gestational Diabetes Mellitus in HIV-infected Pregnant Women: A Systematic Review and Meta-analysis
      4. Continuous Glucose Monitoring in Pregnancy: Importance of Analyzing Temporal Profiles to Understand Clinical Outcomes
      5. Urinary and Serum Angiogenic Markers in Women with Pre-existing Diabetes During Pregnancy and Their Role in Preeclampsia Prediction

      Section 7: Drugs and Therapeutics

      1. Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Non-alcoholic Steatohepatitis in Patients with Type 2 Diabetes
      2. Efficacy of Modern Diabetes Treatments DPP-4i, SGLT-2i, and GLP-1RA in White and Asian Patients with Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials
      3. Clinical and Public Health Implications of 2019 Endocrine Society Guidelines for Diagnosis of Diabetes in Older Adults
      4. Efficacy and Safety of Glimepiride With or Without Linagliptin Treatment in Patients with HNF1A Diabetes (Maturity-Onset Diabetes of the Young Type 3): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial (GLIMLINA)
      5. The Impact of Bariatric Surgery on Incident Microvascular Complications in Patients with Type 2 Diabetes: A Matched Controlled Population-Based Retrospective Cohort Study
      6. Dasiglucagon — A Next-Generation Glucagon Analog for Rapid and Effective Treatment of Severe Hypoglycemia: Results of Phase 3 Randomized Double-Blind Clinical Trial
      7. Meta-analyses of Results from Randomized Outcome Trials Comparing Cardiovascular Effects of SGLT2is and GLP-1RAs in Asian Versus White Patients With and Without Type 2 Diabetes
      8. Antidepressant Use and Glycemic Control in Diabetic Population: A Meta-analysis
      9. Efficacy and Safety of Endothelin Receptor Antagonists in Type 2 Diabetic Kidney Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials
      10. Diabetes Remission Status During Seven-year Follow-up of the Longitudinal Assessment of Bariatric Surgery Study
      11. Insights Into the Early Use of Oral Semaglutide in Routine Clinical Practice: The IGNITE Study
      12. IRWIS (IDegLira Real world Indian Study): A Real-World Observational Study For Use of IDegLira In Indian Patients
      13. Insulin DEgludec in Hospitalized Patients with Type 2 Diabetes (IDEOS Study): What Effects on Glycemic Control, Glycemic Variability and Hypoglycemia
      14. Efficacy and Safety of Insulin Degludec in Renal Transplant Recipients with Pre-existing Diabetes
      15. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 Trial)
      16. Semaglutide 2·4 mg Once a Week in Adults with Overweight or Obesity, and Type 2 Diabetes (STEP 2): a Randomised, Double-blind, Double-dummy, Placebo-controlled, Phase 3 Trial
      17. A Randomized Trial Evaluating the Efficacy and Safety of Fast Acting Insulin Aspart Compared with Insulin Aspart, Both in Combination with Insulin Degludec With or Without Metformin, in Adults with Type 2 Diabetes (ONSET 9)
      18. Impact of Fast-Acting Insulin Aspart on Glycemic Control in Patients with Type 1 Diabetes Using Intermittent- Scanning Continuous Glucose Monitoring Within a Real-World Setting: The GoBolus Study
      19. Critical Appraisals
      20. Understanding Patients’ Willingness to Pay for Biphasic Insulin Aspart 30/70 in a Pen Device for Type 2 Diabetes Treatment in an Out-of-Pocket Payment Market
      21. Saroglitazar, a PPAR Agonist, for Treatment of NAFLD: A Randomized Controlled Double-Blind Phase 2 Trial
      22. Effectiveness of the PPAR Agonist Saroglitazar in Non-alcoholic Steatohepatitis: Positive Data from Preclinical and Clinical Studies
      23. Section 8: Newer Technologies and Future Directions
      24. Dual-Hormone Closed-Loop System Using a Liquid Stable Glucagon Formulation Versus Insulin-Only Closed-Loop System Compared with a Predictive Low Glucose Suspend System: An Open-Label, Outpatient, Single-Center, Crossover, Randomized Controlled Trial
      25. Effect of Flash Glucose Monitoring on Glycemic Control, Hypoglycemia, Diabetes-Related Distress, and Resource Utilization in the Association of British Clinical Diabetologists (ABCD) Nationwide Audit
      26. Diagnosis of Neuropathy and Risk Factors for Corneal Nerve Loss in Type 1 and Type 2 Diabetes: A Corneal Confocal Microscopy Stud
      27. Whole Plantar Nerve Conduction Study: A New Tool for Early Diagnosis of Peripheral Diabetic Neuropathy
      28. The Role of Infrared Dermal Thermometry in the Management of Neuropathic Diabetic Foot Ulcers
      29. Precision Medicine in Diabetes: A Consensus Report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

      Recently viewed products

      © 2026 Book Curl

        • American Express
        • Apple Pay
        • Diners Club
        • Discover
        • Google Pay
        • Maestro
        • Mastercard
        • PayPal
        • Shop Pay
        • Union Pay
        • Visa

        Login

        Forgot your password?

        Don't have an account yet?
        Create account